Clinical Trial Update: Haemocomplettan® P During Aortic Replacement [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Haemocomplettan P during aortic replacement has completed in patients with aortic aneurysm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Aneurysm

Drugs mentioned

• Haemocomplettan P (fibrinogen concentrate)

Snippet

Sponsor: CSL Behring | Conditions: Aortic Aneurysm | Phase 2 | Status: COMPLETED